Skip to main navigation Skip to search Skip to main content

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents

  • César Soutullo
  • , Tobias Banaschewski
  • , Michel Lecendreux
  • , Mats Johnson
  • , Alessandro Zuddas
  • , Colleen Anderson
  • , Richard Civil
  • , Nicholas Higgins
  • , Ralph Bloomfield
  • , Liza A. Squires
  • , David R. Coghill

    Research output: Contribution to journalArticlepeer-review

    Abstract

    There are limited head-to-head data comparing the efficacy of long-acting amfetamine- and methylphenidate-based psychostimulants as treatments for individuals with attention-deficit hyperactivity disorder (ADHD). This post hoc analysis provides the first parallel-group comparison of the effect of lisdexamfetamine dimesylate (lisdexamfetamine) and osmotic-release oral system methylphenidate (OROS-MPH) on symptoms of ADHD in children and adolescents.
    Original languageEnglish
    JournalCNS Drugs
    DOIs
    Publication statusPublished - 26 Jun 2013

    Fingerprint

    Dive into the research topics of 'A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents'. Together they form a unique fingerprint.

    Cite this